FDA approves injectable version of Roche's multiple sclerosis therapy

The Straits Times - World·2024-09-13 12:06

WASHINGTON - The US Food and Drug Administration on Sept 12 approved Roche’s under-the-skin injection to treat patients with multiple sclerosis.

The therapy is already approved as an infusion or IV therapy for multiple sclerosis, which is given twice a year, under the brand name Ocrevus.

……

Other

HOME